Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Disc Medicine, Inc (IRON)  
$30.36 0.41 (1.33%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 24,140,000
Market Cap: 732.89(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.52 - $75.32
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gemeni Therapeutics is a clinical-stage precision medicine company developing therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). Co.'s lead product candidate, GEM103, is a recombinant form of the human complement factor H protein and is designed to address complement hyperactivity and overall dysregulation caused by loss of function mutations thus restoring retinal health in patients with AMD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 652,175
Total Buy Value $0 $0 $0 $15,000,025
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 3
Total Shares Sold 28,918 1,809,345 3,899,867 3,922,367
Total Sell Value $2,009,702 $108,295,610 $210,114,411 $210,161,436
Total People Sold 2 8 12 13
Total Sell Transactions 3 33 52 53
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 117
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ashiya Mona Director   –       •      –    2023-12-14 4 S $56.75 $24,584,100 I/I (433,200) 224,405 53%     
   Orbimed Genesis Gp Llc Director   –       •      –    2023-12-14 4 S $56.75 $24,584,100 I/I (433,200) 224,405 53%     
   Bitterman Kevin Director   –       •      –    2023-12-14 4 S $58.27 $1,197,567 I/I (20,549) 806,160 53%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-12-14 4 S $58.27 $1,197,567 I/I (20,549) 806,160 53%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-12-14 4 S $58.27 $1,796,437 D/D (30,825) 1,479,686 53%     
   Orbimed Genesis Gp Llc Director   –       •      –    2023-12-14 4 S $57.73 $11,546 I/I (200) 727,807 53%     
   Ashiya Mona Director   –       •      –    2023-12-14 4 S $57.73 $11,546 I/I (200) 727,807 53%     
   Bitterman Kevin Director   –       •      –    2023-12-13 4 S $59.99 $212,865 I/I (3,548) 826,709 55%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-12-13 4 S $59.99 $212,865 I/I (3,548) 826,709 55%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-12-13 4 S $59.99 $319,357 D/D (5,323) 1,510,511 55%     
   Orbimed Genesis Gp Llc Director   –       •      –    2023-12-13 4 S $58.56 $6,248,352 I/I (106,700) 281,505 55%     
   Ashiya Mona Director   –       •      –    2023-12-13 4 S $58.56 $6,248,352 I/I (106,700) 281,505 55%     
   Bitterman Kevin Director   –       •      –    2023-12-12 4 S $59.87 $3,263,328 I/I (51,967) 830,257 54%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-12-12 4 AS $65.22 $163,062 D/D (2,500) 2,500 -54%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-12-12 4 OE $2.65 $6,625 D/D 2,500 5,000     -
   White William Richard   –       •      –    2023-12-12 4 S $59.44 $2,118,239 D/D (33,511) 0 54%     
   White William Richard   –       •      –    2023-12-12 4 OE $2.65 $203,883 D/D 33,511 33,511     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-12-12 4 S $59.87 $3,263,328 I/I (51,967) 830,257 54%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2023-12-12 4 S $59.87 $4,895,032 D/D (77,951) 1,515,834 54%     
   Orbimed Genesis Gp Llc Director   –       •      –    2023-12-12 4 S $60.16 $1,642,368 I/I (27,300) 295,605 54%     
   Ashiya Mona Director   –       •      –    2023-12-12 4 S $60.16 $1,642,368 I/I (27,300) 295,605 54%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-12-05 4 AS $55.29 $142,299 D/D (2,541) 2,500 -47%     
   Bryce Joanne Chief Financial Officer   •       –      –    2023-12-05 4 OE $1.01 $1,294 D/D 1,281 5,041     -
   Khara Rahul General Counsel   •       –      –    2023-11-22 4 AS $50.34 $517,333 D/D (10,000) 0 -43%     
   Khara Rahul General Counsel   •       –      –    2023-11-22 4 OE $14.69 $146,900 D/D 10,000 10,000     -
  117 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us